title: Blinatumomab approved for rare leukemia.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D018033:Antibodies, Bispecific / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007938:Leukemia / Q000175:diagnosis / Q000188:drug therapy*; D014481:United States
chemical_list: D018033:Antibodies, Bispecific; D000970:Antineoplastic Agents; C510808:blinatumomab